Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
Volume -, Issue -, Pages 1-18
Publisher
Informa UK Limited
Online
2023-07-10
DOI
10.1080/13651501.2023.2231047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?
- (2022) Pavel Mohr et al. Frontiers in Psychiatry
- Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia
- (2022) Elmars Rancans et al. Frontiers in Psychiatry
- Molecular Imaging of Dopamine Partial Agonists in Humans: Implications for Clinical Practice
- (2022) Xenia M. Hart et al. Frontiers in Psychiatry
- Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice
- (2022) David Fraguas et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Dopamine partial agonists: a discrete class of antipsychotics
- (2022) David Taylor et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post‐hoc analysis of a long‐term open‐label study
- (2021) Jun Ishigooka et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies
- (2021) Miquel Bernardo et al. ADVANCES IN THERAPY
- Immediate versus wait-and-gradual discontinuation in antipsychotic switching: A meta-analysis
- (2020) Hiroyoshi Takeuchi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel
- (2020) Andrea Fagiolini et al. Annals of General Psychiatry
- Switching strategies for antipsychotic monotherapy in schizophrenia: a multi-center cohort study of aripiprazole
- (2019) Yoshiaki Obayashi et al. PSYCHOPHARMACOLOGY
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
- (2019) Thomas RE Barnes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Long-term safety and effectiveness of brexpiprazole in Japanese patients with schizophrenia: A 52-week, open-label study
- (2018) Jun Ishigooka et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians’ choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study
- (2018) Christoph U. Correll et al. CNS SPECTRUMS
- Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
- (2017) György Németh et al. LANCET
- Gradual vs. wait-and-gradual discontinuation in antipsychotic switching: A meta-analysis
- (2017) Hiroyoshi Takeuchi et al. SCHIZOPHRENIA RESEARCH
- Rapid vs. slow antipsychotic initiation in schizophrenia: A systematic review and meta-analysis
- (2017) Hiroyoshi Takeuchi et al. SCHIZOPHRENIA RESEARCH
- Cariprazine in the treatment of schizophrenia
- (2016) Suresh Durgam et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study
- (2016) W. Wolfgang Fleischhacker et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial
- (2016) Suresh Durgam et al. SCHIZOPHRENIA RESEARCH
- Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists
- (2015) Andrea Fagiolini et al. EXPERT OPINION ON PHARMACOTHERAPY
- The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out
- (2015) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Cariprazine in Acute Exacerbation of Schizophrenia
- (2015) Suresh Durgam et al. JOURNAL OF CLINICAL PSYCHIATRY
- Fast Versus Slow Strategy of Switching Patients With Schizophrenia to Aripiprazole From Other Antipsychotics
- (2015) Tzung-Jeng Hwang et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial
- (2014) Suresh Durgam et al. SCHIZOPHRENIA RESEARCH
- Switching Antipsychotic Medications to Reduce Adverse Event Burden in Schizophrenia: Establishing Evidence-Based Practice
- (2013) John W. Newcomer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study
- (2012) Yuejin Chen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
- (2011) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- Switching among Antipsychotics in Everyday Clinical Practice: Focus on Ziprasidone
- (2011) Alessandro Rossi et al. POSTGRADUATE MEDICINE
- Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study
- (2009) Chi-Un Pae et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder
- (2009) Chang Yoon Kim et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Switching to Aripiprazole in Outpatients with Schizophrenia Experiencing Insufficient Efficacy and/or Safety/Tolerability Issues with Risperidone: A Randomized, Multicentre, Open-label Study
- (2009) V. Ryckmans et al. PHARMACOPSYCHIATRY
- A Randomized, Open-Label Comparison of 2 Switching Strategies to Aripiprazole Treatment in Patients With Schizophrenia
- (2008) Hiroyoshi Takeuchi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision
- (2008) Borwin Bandelow et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now